finance.yahoo.com
Every finance.yahoo.com story we have translated and published, newest first. · 13,390 stories
Finance
Is BHP Group (BHP) the Missing Piece in NexGen Energy (NXE)’s $1 Billion Financing Plan?
Finance
Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial
Finance
Jim Cramer Says Stay Long Airbnb Stock (ABNB) Despite Fee Concerns
Finance
Should You Dump Airline Stocks With the Iran War Still Simmering?
Finance
Jim Cramer Says Salesforce’s (CRM) Anthropic Partnership Silences AI Disruption Fears
Finance
Can TotalEnergies (TTE)’s Shell (SHELL) Deal Unlock More Growth?
Finance
How to Play the Post-Earnings Selloff in Marvell Technology Stock
Finance
Motive and Highway Restore ELD Data Access After Integration Dispute
Finance
Kevin Warsh gets what every Fed chair hopes for: a bond market that trusts his word
Finance
Is Chevron (CVX) Outperforming TotalEnergies (TTE) in the Energy Race?
Finance
Software Stocks Are Divided as AI Creates a Deep Rift Between ‘Haves’ and ‘Have Nots’
Finance
Marvell’s (MRVL) AI Growth Is Real — The Market Just Wants It Now
Finance
Targa Resources (TRGP) vs. ExxonMobil (XOM): Which Stock Is the Better Energy Bet?
Finance
Vanguard’s wealthtech deal sets table for public-meets-private expansion
Finance
Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?
Finance
Sui Price Risks 12% Drop as Ecosystem Growth Stalls
Finance
Netflix Stock Is Up 25% From Its 2026 Lows. More Gains for NFLX Could Be in Store.
Finance
Will Paramount Skydance (PSKY)’s Warner Bros. Discovery (WBD) Deal Unlock Major Investor Value?
Finance
Barrick Mining (B) Has an IPO Catalyst. Newmont Corporation (NEM) Has the Cash. Which Gold Stock Wins?
Finance
Bitwise Solana ETF Crosses $1 Billion Mark
Finance
Union Pacific (UNP) is Winning the Railroad Race. Can Norfolk Southern (NSC) Catch Up through the Merger?
Finance
PayPal Stock Drops as Buyout Plans Fall Through. Where Barchart Options Data Says PYPL Could Be Headed Next.
Finance
Analysis-Warsh's 'quieter Fed' now includes a smidgen of guidance
Finance
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
Page 283 / 558